About AffinityImmuno
AffinityImmuno Inc. is a Canadian biotechnology company providing high quality R&D products and services to for the global community with emphasis on biological drugs and biosimilars. We specialize in antibodies and bioanalytical methodologies for cancer, autoimmune disorders, and COVID-19. We offer several off-the-shelf ELISA kits and legacy monoclonal antibodies. We leverage our combined experience of over 30 years working in immunology and analytical chemistry to offer high quality products and service to quickly meet new challenges.
AffinityImmuno is highly adaptable and can quickly pivot to meet the needs of the bioscience community. With the onset of the COVID-19 pandemic, we were quickly able to leverage our knowledge and skills to develop some of the first polyclonal antibodies to SARS-CoV-2 and a surrogate Virus Neutralization Test.
Products
PEG kits
ELISA kits for trastuzumab
Rituximab
Pembrolizumab
Adalilumab
Bevacizumab
Sectors
- antibodies
- custom services
- kits
Custom Services
Method development and validation for peptides, proteins and biological drugs.
Custom polyclonal antibody production in rabbits and chickens, both crude and affinity purified antibodies are available.